<DOC>
	<DOCNO>NCT03099031</DOCNO>
	<brief_summary>The purpose study validate Ottawa score ( risk thromboembolic recurrence ) cancer patient thromboembolic disease treat tinzaparin ( InnohepÂ® )</brief_summary>
	<brief_title>Non Interventional Study Validation Ottawa Score Cancer Patients With Venous Thromboembolism ( VTE )</brief_title>
	<detailed_description>The Ottawa score clinical predictive score aim stratify thromboembolic recurrence cancer patient accord identified clinical risk factor histological type tumor . This score never validate externally prospective way patient treat tinzaparin . The objective observational prospective study enroll cancer patient TED treat tinzaparin planned period 6 month collect data thromboembolic recurrence , major hemorrhage , death heparin-induced thrombocytopenia</detailed_description>
	<mesh_term>Thromboembolism</mesh_term>
	<mesh_term>Venous Thromboembolism</mesh_term>
	<mesh_term>Tinzaparin</mesh_term>
	<criteria>Cancer patient histologically confirm , active evolving , solid liquid tumour , Suspected malignant tumour confirm within month index VTE occurrence Treated specific metastatic adjuvant anticancer treatment Patients recent diagnosis document symptomatic incidental VTE prescription tinzaparin 6 month Proximal distal VTE low limb Pulmonary embolism Inferior superior vena cava thrombosis Iliac vein thrombosis Skin cancer melanoma Life expectancy le 6 month Superficial isolate thrombosis Isolated subsegmental pulmonary embolism Cerebral , visceral thrombosis Superior limbs VTE Central catheter thrombosis Patients treat anticoagulant 7 day</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Ottawa score</keyword>
	<keyword>tinzaparin</keyword>
	<keyword>low-molecular weight heparin</keyword>
	<keyword>anticoagulant</keyword>
	<keyword>venous thrombosis</keyword>
	<keyword>thromboembolism</keyword>
	<keyword>hemostatic disorder</keyword>
	<keyword>vascular disease</keyword>
	<keyword>neoplasm</keyword>
	<keyword>breast neoplasm</keyword>
	<keyword>lung neoplasm</keyword>
	<keyword>prostatic neoplasm</keyword>
	<keyword>colorectal neoplasm</keyword>
	<keyword>genital neoplasm</keyword>
	<keyword>urogenital neoplasm</keyword>
	<keyword>intestinal neoplasm</keyword>
	<keyword>digestive system neoplasm</keyword>
	<keyword>lymphoma</keyword>
	<keyword>leukemia</keyword>
	<keyword>multiple myeloma</keyword>
	<keyword>lymphoproliferative disorder</keyword>
	<keyword>myeloproliferative disorder</keyword>
	<keyword>lymphatic disease</keyword>
</DOC>